WIPF1 antibody (pSer488) (PE)
Quick Overview for WIPF1 antibody (pSer488) (PE) (ABIN1177221)
Target
See all WIPF1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- pSer488
-
Brand
- BD Phosflow™
-
Purification
- The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
-
Immunogen
- Phosphorylated Human WIP Peptide
-
Isotype
- IgG1 kappa
-
-
-
-
Sample Volume
- 20 μL
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Aqueous buffered solution containing BSA and ≤0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The antibody was conjugated with R-PE under optimum conditions, and unconjugated antibody and free PE were removed.
-
-
-
: "The verprolin family of proteins: regulators of cell morphogenesis and endocytosis." in: FEBS letters, Vol. 579, Issue 24, pp. 5253-9, (2005) (PubMed).
-
-
- WIPF1 (WAS/WASL Interacting Protein Family, Member 1 (WIPF1))
-
Alternative Name
- WIP
-
Background
- Wiskott-Adrich syndrome protein (WASP)-Interacting Protein (WIP) is a member of the verprolin family of proteins that regulate cytoskeletal organization in a wide variety of cellular activities, including endocytosis, cellular adhesion and migration, mast cell degranulation, and lymphocyte activation. The 503-amino acid WIP protein contains binding sites for actin (globular and filamentous) and other proteins that are involved in the regulation of actin polymerization, such as WASP, N-WASP, profilin, cortactin, Hck, and NCK. As its functions imply, WIP is localized in actin-rich cell structures. The K32-824 monoclonal antibody recognizes the phosphorylated serine 488 (pS488) of human WIP. The orthologous phosphorylation sites in mouse and rat WIP are S478 and S472, respectively.
-
Pathways
- RTK Signaling
Target
-